Genotoxicity Assessment for Patients Undergoing Radiation Treatment
United States47 participantsStarted 2006-04
Plain-language summary
The purpose of the research study is to evaluate an automated, laser-based technique for measuring DNA damage caused by radiation during cancer treatment in immature red blood cells.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients that are scheduled to begin radiotherapy to the large-field chest region are eligible if:
* Daily radiation dose is between 1.8 and 5 Gy/day
* Any single dimension of field size is ≥ 15 cm
* Provision of written informed consent
or
* Or patients receiving IMRT or Tomotherapy, when low-dose radiation is spread out to the normal tissues, irrespective of daily radiation doses.
* Or patients receiving radionucleotides as part of the medical treatment (cancer or non-malignant conditions)
* Or patients who will receive diagnostic CT scans, PET/CT scans, mammograms, or diagnostic imaging requiring radionucleotides